Barclays PLC boosted its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) by 3.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,690,279 shares of the company’s stock after acquiring an additional 48,536 shares during the period. Barclays PLC owned about 0.65% of Ryan Specialty worth $108,449,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently bought and sold shares of RYAN. JPMorgan Chase & Co. lifted its holdings in shares of Ryan Specialty by 107.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock worth $30,504,000 after purchasing an additional 238,064 shares during the last quarter. Bar Harbor Wealth Management lifted its stake in Ryan Specialty by 5.9% in the fourth quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company’s stock valued at $10,835,000 after buying an additional 9,482 shares during the last quarter. Teachers Retirement System of The State of Kentucky boosted its holdings in shares of Ryan Specialty by 51.5% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 30,760 shares of the company’s stock valued at $2,042,000 after acquiring an additional 10,460 shares during the period. GAMMA Investing LLC grew its position in shares of Ryan Specialty by 38.1% during the fourth quarter. GAMMA Investing LLC now owns 1,725 shares of the company’s stock worth $111,000 after acquiring an additional 476 shares during the last quarter. Finally, Embree Financial Group increased its holdings in shares of Ryan Specialty by 64.1% in the 4th quarter. Embree Financial Group now owns 83,212 shares of the company’s stock worth $5,339,000 after acquiring an additional 32,500 shares during the period. 84.82% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on the stock. Keefe, Bruyette & Woods reduced their target price on shares of Ryan Specialty from $76.00 to $75.00 and set an “outperform” rating for the company in a research note on Wednesday, April 9th. Royal Bank of Canada reduced their price objective on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research report on Friday, February 21st. Wells Fargo & Company lowered their target price on Ryan Specialty from $69.00 to $66.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 10th. TD Cowen assumed coverage on Ryan Specialty in a research report on Thursday, April 10th. They set a “buy” rating and a $89.00 price target for the company. Finally, UBS Group raised their price target on Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, Ryan Specialty presently has an average rating of “Hold” and a consensus target price of $75.67.
Ryan Specialty Price Performance
NYSE:RYAN opened at $73.08 on Wednesday. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The business’s 50-day moving average price is $70.25 and its 200 day moving average price is $68.97. Ryan Specialty Holdings, Inc. has a 52-week low of $48.48 and a 52-week high of $77.16. The firm has a market cap of $19.14 billion, a P/E ratio of 105.91, a PEG ratio of 1.19 and a beta of 0.66.
Ryan Specialty (NYSE:RYAN – Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The business had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. As a group, sell-side analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.
Ryan Specialty Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th were given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date was Tuesday, March 4th. This is an increase from Ryan Specialty’s previous quarterly dividend of $0.11. Ryan Specialty’s dividend payout ratio is 69.57%.
Insider Transactions at Ryan Specialty
In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 35,000 shares of the company’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $66.35, for a total transaction of $2,322,250.00. Following the completion of the sale, the director now directly owns 20,909 shares of the company’s stock, valued at approximately $1,387,312.15. This represents a 62.60 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Insiders sold a total of 176,894 shares of company stock valued at $11,779,720 in the last three months. 11.10% of the stock is currently owned by corporate insiders.
Ryan Specialty Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Further Reading
- Five stocks we like better than Ryan Specialty
- How to Use Stock Screeners to Find Stocks
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- Business Services Stocks Investing
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Congress! Who Traded What During the Tariff-Induced MeltdownÂ
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.